findmyKOL

Ildiko Lingvay, MD

Enriched profile

Professor, Department of Internal Medicine, Division of Endocrinology · UT Southwestern Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusDiabetes Treatment and Management+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2007–2011

Ildiko Lingvay is Professor, Department of Internal Medicine, Division of Endocrinology at UT Southwestern Medical Center. OpenAlex indexes 439 publications with 46,926 citations (h-index 90); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Ildiko Lingvay, MD, is Professor, Department of Internal Medicine, Division of Endocrinology at UT Southwestern Medical Center. The public record shows 439 publications with 46,926 citations (h-index 90), centered on Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 29 companies, 1 NIH-funded awards (2007–2011).

  • Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
  • Top research focus: Diabetes Treatment and Management
  • 9 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 29 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 2 Diabetes8 trialsObesity4 trialsESRD / Dialysis1 trialHeart Failure1 trialRenal Insufficiency1 trialDiabetic Nephropathies1 trial

Research focus

OpenAlex concept fingerprint
Diabetes Treatment and ManagementDiabetes Management and ResearchMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes

Drugs & molecules

across trials, industry payments and publications
Mounjarogeneric · TirzepatideClinical trials—Industry payments13Publications3Steglatrogeneric · ErtugliflozinClinical trials—Industry payments9Publications1Victozageneric · LiraglutideClinical trials—Industry payments5Publications5Toujeogeneric · Insulin glargineClinical trials—Industry payments6Publications3Invokanageneric · CanagliflozinClinical trials—Industry payments5Publications1Tresibageneric · Insulin degludecClinical trials—Industry payments1Publications2Zegaloguegeneric · DasiglucagonClinical trials—Industry payments9Publications—SOLIQUA 100Clinical trials—Industry payments6Publications—Korlymgeneric · MifepristoneClinical trials—Industry payments1Publications—Tzieldgeneric · TeplizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials1Industry payments3Novo Nordisk ASClinical trials—Industry payments100Eli Lilly and CompanyClinical trials—Industry payments99Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments58Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments18Medical Device Business Services, Inc.Clinical trials—Industry payments13Sanofi-Aventis U.S. LLCClinical trials—Industry payments13Merck Sharp & Dohme LLCClinical trials—Industry payments11Abbvie Inc.Clinical trials—Industry payments10Pfizer Inc.Clinical trials—Industry payments10Neurocrine BioSciences, Inc.Clinical trials—Industry payments9Zealand Pharma US, Inc.Clinical trials—Industry payments9AstraZeneca Pharmaceuticals LPClinical trials—Industry payments8F. Hoffmann-La Roche AGClinical trials—Industry payments8Genentech, Inc.Clinical trials—Industry payments7Novo Nordisk IncClinical trials—Industry payments7Zealand Pharma A/SClinical trials—Industry payments7University of Texas Southwestern Medical CenterClinical trials6Industry payments—Amgen Inc.Clinical trials—Industry payments5Janssen Scientific Affairs, LLCClinical trials—Industry payments5Shionogi IncClinical trials—Industry payments5Boehringer Ingelheim International GmbHClinical trials—Industry payments4AstraZeneca UK LimitedClinical trials—Industry payments3Merck Sharp & Dohme CorporationClinical trials—Industry payments3AstraZeneca ABClinical trials—Industry payments2Alessandro DoriaClinical trials1Industry payments—Corcept TherapeuticsClinical trials—Industry payments1Dr.Reddy's Laboratories,Inc.Clinical trials—Industry payments1Ethicon US, LLCClinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
439publications

Distinct works indexed by OpenAlex, matched via ORCID; 100 in PubMed.

46,926citations

Total citations across indexed works.

90h-index

Hirsch index (OpenAlex). i10-index 198.

Clinical & industry

trials, payments and federal funding
9clinical trials

Investigator role on registered studies.

View trials ↓
29companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2007–2011

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Member

    American Diabetes Association Professional Practice Committee

    2025
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    55.1%
    l-Thyroxine55.1%
    Levothyroxine Sodium68%Synthroid32%
    Part D<11 patients
  • Metabolism & gastrointestinal

    44.9%
    SGLT2 inhibitor17%
    Jardiance100%
    Part D<11 patients
    GLP-1 receptor agonist11.6%
    Ozempic100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B), 2023100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

43 congress contributions (2018–2025) across AACE, ADA, ENDO per OpenAlex. The most recent:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Sarit Polsky46Melanie J. Davies43Rozalina G. McCoy42Raveendhara R. Bannuru42Glenn Matfin42Robert C. Stanton42Jane Jeffrie Seley42Laya Ekhlaspour42Scott J. Pilla42Grazia Aleppo42Kamlesh Khunti42Alissa R. Segal42Nuha A. ElSayed39Julio Rosenstock35Vanita R. Aroda33Richard E. Pratley33A. Michael Lincoff31Steven E. Kahn28Helen M. Colhoun26Elizabeth A. Beverly25Robert F. Kushner25Ole Kleist Jeppesen23John Deanfield22Dennis Bruemmer22Donna H. Ryan22Marisa E. Hilliard21Mary Lou Perry21Kirthikaa Balapattabi21Rayhan Lal21Thomas A. Wadden21Justin B. Echouffo‐Tcheugui21John B. Buse21Priya Prahalad21Elizabeth J. Pekas21Harpreet S. Bajaj21Billy S. Collins21Kathaleen Briggs Early21Dennis Bruemmer21Robert A. Gabbay21Jorge Plutzky20

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/ildiko-lingvay-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Ildiko-Lingvay

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/lingvay

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/IldikoLingvay

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.S.C.S. (with distinction)

    UT Southwestern Medical Center

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • M.P.H.

    University of Texas Health Science Center at Houston School of Public Health

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • M.D. with honors

    Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Internal Medicine residency

    Texas Tech University Health Sciences Center, Lubbock, TX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
  • Fellowship

    Endocrinology, Diabetes and Metabolism, UT Southwestern Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
  • Board certified

    Endocrinology, Diabetes and Metabolism (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
  • Board certified

    Obesity Medicine (American Board of Obesity Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Office of Clinical Trials Management, UT Southwestern (institutional oversight of clinical trial approvals)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Secondary appointment

    Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.